Patents Assigned to Luoda Pharma Pty Ltd
  • Methods of treating topical microbial infections
    Patent number: 9943500
    Abstract: The invention is a method and composition for treating a topical microbial infection in a subject. The method includes the step of administering a therapeutically effective amount of a polyether ionophore, or a therapeutically acceptable salt thereof, to the subject.
    Type: Grant
    Filed: February 10, 2014
    Date of Patent: April 17, 2018
    Assignee: Luoda Pharma Pty Ltd
    Inventor: Stephen Page
  • Liquid Formulation
    Publication number: 20180028665
    Abstract: The invention relates to a liquid formulation comprising propylene glycol and an effective amount of an inodilator, an angiotensin converting enzyme inhibitor, or a combination of an inodilator and an angiotensin converting enzyme inhibitor and to use of the formulation for treating cardiac disease and/or hypertension.
    Type: Application
    Filed: October 5, 2017
    Publication date: February 1, 2018
    Applicant: Luoda Pharma Pty Ltd
    Inventors: Nicholas Bova, Stephen Page, Giuseppe Pippia
  • Liquid formulation
    Patent number: 9808529
    Abstract: The invention relates to a liquid formulation comprising propylene glycol and an effective amount of an inodilator, an angiotensin converting enzyme inhibitor, or a combination of an inodilator and an angiotensin converting enzyme inhibitor and to use of the formulation for treating cardiac disease and/or hypertension.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: November 7, 2017
    Assignee: Luoda Pharma Pty Ltd
    Inventors: Nicholas Bova, Stephen Page, Giuseppe Pippia